SCHEMBL8310074

SCHEMBL8310074

COc1ccc(/C(C)=N\OCCOc2ccc(CC3SC(=O)N(C(c4ccccc4)(c4ccccc4)c4ccccc4)C3=O)cc2)cn1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PPARG P37231 11/20 0.54
FFAR1 O14842 5/20 0.36
GAA P10253 1/20 0.34
HTT P42858 1/20 0.33
RARG P13631 1/20 0.32
RXRA P19793 1/20 0.32
MPC2 O95563 1/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2C9 P11712 1/20 0.32
PPARA Q07869 1/20 0.32
MAPT P10636 1/20 0.31
S1PR1 P21453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8310076 1.00 PPARG (0.54) PPARGFFAR1GAAHTTRARG
SCHEMBL8304974 0.93 PPARG (0.54) PPARGFFAR1GAAHTTRARG
SCHEMBL8304976 0.93 PPARG (0.54) PPARGFFAR1GAAHTTRARG
SCHEMBL8305869 0.92 PPARG (0.52) PPARGFFAR1HTTRARGRXRA
SCHEMBL8305873 0.92 PPARG (0.52) PPARGFFAR1HTTRARGRXRA
SCHEMBL8305170 0.89 PPARG (0.69) PPARGFFAR1HTTRARGRXRA
SCHEMBL8305173 0.89 PPARG (0.69) PPARGFFAR1HTTRARGRXRA
SCHEMBL8307062 0.87 PPARG (0.55) PPARGFFAR1GAAHTTMAPT
SCHEMBL8305087 0.87 PPARG (0.51) PPARGFFAR1GAAHTTMAPT
SCHEMBL8307060 0.87 PPARG (0.55) PPARGFFAR1GAAHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed